Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility Spectrometry (NCT05384470) | Clinical Trial Compass
CompletedNot Applicable
Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility Spectrometry
United States32 participantsStarted 2021-08-01
Plain-language summary
This Phase II STTR program consists of two major goals within the overarching goal of developing and validating a proprietary device (BID2) for marijuana and opioid detection in breath samples.
Who can participate
Age range21 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
* Capable of understanding and complying with the protocol
* In good physical and mental health (normal physical exam, ECG, blood and urine chemistries
* Absence of history or laboratory evidence of diabetes)
* Body Mass Index between 18-30,
* Inclusive Age 21-50 years (age will be verified by driver's license or other valid form of identification)
* Have a stable living situation with current postal address.
Exclusion criteria
* Meets criteria for current alcohol or substance use disorders (Past alcohol or substance use disorders greater than 3 years ago is acceptable)
* Concurrent diagnosis of Axis 1 disorder be maintained on an antipsychotic or antidepressant medication
* Taking prescription medications except certain short-term anti-fungal agents and some topical creams for dermal condition
* Heavy alcohol drinkers (greater than 15 drinks per week)
* Tobacco use greater than 5 cigarettes per day
* History of major head trauma resulting in cognitive impairment or history of seizure disorder
* Heavy caffeine use (greater than 500 mg on a regular daily basis)
* Has active hepatitis and/or aspartate aminotransferase (AST), alanine aminotransferase (ALT)\> 3x the upper limit of normal
* For female participants, a positive pregnancy test.